Modulation of oncogenic transcription factors by bioactive natural products in breast cancer
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 128, 376-388
Abstract
No abstract availableKeywords
Funding Information
- PPP Grant (PG048-2015A)
This publication has 154 references indexed in Scilit:
- The Role of MicroRNAs in Breast Cancer Stem CellsInternational Journal of Molecular Sciences, 2013
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and SenescenceCell, 2012
- The Anticancer Effects of Resveratrol: Modulation of Transcription FactorsNutrition and Cancer, 2012
- Apigenin: A Promising Molecule for Cancer PreventionPharmaceutical Research, 2010
- Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cellsBiochemical and Biophysical Research Communications, 2009
- Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2Nature Cell Biology, 2007
- Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 2007
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002